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Abstract 1 
Background: There is a substantial proportion of patients who drop out of treatment before 2 
they receive minimally adequate care. They tend to have worse health outcomes than those 3 
who complete treatment. Our main goal is to describe the frequency and determinants of 4 
dropout from treatment for mental disorders in low, middle- and high-income countries. 5 
Methods: Respondents from 13 low- or middle-income countries (N = 60,224) and 15 in 6 
high income countries (N = 77,303) were screened for mental and substance use disorders. 7 
Cross-tabulations were used to examine the distribution of treatment and dropout rates for 8 
those who screened positive. The timing of dropout was examined using Kaplan-Meier 9 
curves. Predictors of dropout were examined with survival analysis using a logistic link 10 
function. 11 
Results: Dropout rates are high, both in high-income (30%) and low-middle income (45%) 12 
countries. Dropout mostly occurs during the first two visits. It is higher in general medical 13 
rather than in specialist settings (nearly 60% vs 20% in lower income settings). It is also 14 
higher for mild and moderate than for severe presentations. The lack of financial protection 15 
for mental health services is associated with overall increased dropout from care. 16 
Conclusions: Extending financial protection and coverage for mental disorders may reduce 17 
dropout. Efficiency can be improved by managing the milder clinical presentations at the 18 
entry point to the mental health system, providing adequate training, support and specialist 19 
supervision for non-specialists, and streamlining referral to psychiatrists for more severe 20 
cases. 21 
Keywords: Dropout; mental health; survival analysis; WMH surveys 22 
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Introduction 23 
The treatment gap in mental disorders is well-established. A recent report from the 24 
WHO World Mental Health (WMH) Surveys showed that only 13.7% of individuals with a 25 
12-month Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition/Composite 26 
International Diagnostic Interview (DSM-IV/CIDI) mental disorder in low/lower-middle 27 
income countries, 22.0% in upper-middle income countries, and 36.8% in high income 28 
countries receive any type of professional treatment (Evans-Lacko et al., 2018). Only a 29 
minority of the people getting treatment received at least minimally adequate treatment when 30 
compared to accepted treatment guidelines. A major reason for this is treatment dropout 31 
(Degenhardt et al., 2017; Alonso et al., 2018; Evans-Lacko et al., 2018). 32 
It has long been known that premature interruption of mental health treatment is a 33 
common event that has negative consequences both for the patients and the mental health 34 
care system (Swift & Greenberg, 2012). Numerous studies have been conducted to 35 
understand the causes and consequences of treatment dropout (Fassino, Pierò, Tomba, & 36 
Abbate-Daga, 2009; Roos & Werbart, 2013; Cooper & Conklin, 2015). These studies have 37 
identified socio-demographic, provider and clinical factors associated with different dropout 38 
rates. For example, young age among adults (Wang, 2007; Xiang et al., 2010), lower socio-39 
economic status (income and education) (Centorrino et al., 2002; Warden et al., 2009a), 40 
ethnic minority status (Wang, 2007), and lack of health insurance (Edlund et al., 2002) have 41 
all been linked to increased probability of treatment dropout. However, other studies have not 42 
found a consistent relationship between these or other sociodemographic factors and 43 
treatment dropout (Olfson et al., 2009; Hoyer et al., 2016). High variability has also been 44 
reported in the frequency of dropout. For example, two meta-analyses including studies of 45 
psychotherapeutic treatment for a mental disorder reported mean dropout rates of 19.7% 46 
(Swift & Greenberg, 2012) and 47% (Wierzbicki & Pekarik, 1993). Dropout has also been 47 
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studied for specific disorders, including depression, posttraumatic stress (PTSD), gambling, 48 
substance use disorders (SUD), and eating disorders, among others. For example, Roberts 49 
Murphy, Turner and Sharman (2020) found that for gambling disorder the treatment dropout 50 
rate was 51.3% and significantly associated with older age, higher education, higher levels of 51 
debt, online gambling, gambling on poker, shorter duration of treatment, higher depression, 52 
experience of previous treatment programs and medication, and adverse childhood 53 
experiences; Belleau et al. (2017) observed that among individuals with PTSD and SUD, 35 54 
to 62% of individuals drop out of treatment; and Huas et al. (2011) found that for anorexia 55 
the dropout rate was above 50%. The inconsistency of findings, variability of methods, and 56 
the fact that the vast majority of studies have been carried out only in high-income countries 57 
limit generalizability. Moreover, most studies have focused on the analysis of treatments 58 
provided for a single disorder in a single treatment sector, which may overestimate dropout 59 
from overall sources of care (Olfson et al., 2009). 60 
 The WMH Survey Initiativeis the largest effort to date to estimate the burden of 61 
mental disorders worldwide, providing population epidemiological data of the prevalence, 62 
correlates and treatment for mental disorders in all the continents (Kessler et al., 2009; 63 
Andrade et al., 2014). The WMHSI has developed a consistent methodology to estimate the 64 
burden of mental and substance use disorders. Every year new countries join the initiative, 65 
which means that the same survey protocol is implemented in a new country or region, 66 
increasing our sample size and expanding the applicability of our results. In addition to 67 
previously reported results (Wells et al., 2013), this study includes data from new surveys 68 
conducted in Argentina, Medellin (Colombia), Murcia (Spain), Peru, and Poland. It also 69 
includes new variables and stratifies the analyses by early dropout (i.e. dropping out after just 70 
1 or 2 visits) and late dropout (i.e. after the third or subsequent visits).  Our objective is to 71 
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describe the frequency and determinants of dropout in population representative samples 72 
from low, middle- and high-income countries or regions.  73 
From a health systems perspective, dropout from care represents a relevant outcome: 74 
it points to an inefficiency that frustrates the successful efforts of the person and the system to 75 
produce a clinical encounter. Indeed, several steps need to take place before such an 76 
encounter is possible: the person (or their significant others) needs to acknowledge a 77 
problem, reach out to a health care provider, and overcome any barriers to accessibility (such 78 
as wait times, out of pocket costs, paperwork, etc). So, understanding the dropout 79 
phenomenon and its determinants better is of the utmost importance. As will be described in 80 
more detail in the following section, we have developed a distinction between “early” and 81 
“late” dropout, depending on whether it occurs during the first two encounters or after the 82 
third. This distinction seeks to capture an important clinical consideration: whether the initial 83 
contact was somehow frustrated or dissatisfactory for the patient, or whether the initial 84 
contact was potentially established, treatment initiated, and then interrupted.  85 
 86 
Methods and Procedures 87 
Sample 88 
Thirteen WMH surveys were carried out in countries classified by the World Bank as 89 
low- or middle-income countries at the time of data collection (combined N = 60,224; 90 
weighted mean response rate 81.1%) and 15 in countries classified as high-income (combined 91 
N = 77,303; weighted response rate 63.5%) (Table 1). Eighteen of the 28 surveys (6 in 92 
low/middle-income countries and 12 in high-income countries) were of nationally 93 
representative multistage clustered area probability household samples. Of the surveys that 94 
were not nationally representative, two included all parts of the country with the exception of 95 
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deeply rural areas, one included only selected regions of the country, and the remaining seven 96 
included only one or more urbanized areas.  97 
(Table 1 about here) 98 
The interviews were carried out face-to-face by lay interviewers monitored closely by 99 
supervisors who were trained by the WMH professional survey administration staff from the 100 
Survey Research Center (SRC) at the University of Michigan’s Institute for Social Research. 101 
Training and field quality control procedures are discussed in more detail elsewhere (Pennell 102 
et al., 2008). The interviews in most surveys were in two parts. All respondents were 103 
administered the Part I interview, which contained assessments of core psychiatric disorders. 104 
A subsample of Part I respondents, which included 100% of those with a Part I psychiatric 105 
disorder and a probability sample of other Part I respondents, were then administered Part II. 106 
This two-part subsampling was done to reduce survey burden among respondents who did 107 
not have a disorder. All surveys used a Part I weight to adjust for differences in within-108 
household probability of selection and to post-stratify for discrepancies between the sample 109 
and population on known demographic and geographic variables. A Part II weight was then 110 
used to adjust for the under-sampling of Part I respondents who did not have any Part I 111 
disorder. These weighting procedures are discussed in more detail elsewhere (Heeringa et al., 112 
2008).  113 
Measures 114 
Translation and administration procedures: The WMH interview schedule was 115 
originally developed in English. Translation, back-translation, and harmonization of the 116 
interview in local languages for use in the WMH surveys were carried out in each country 117 
using WHO guidelines and monitored by a centralized back-translation monitoring 118 
committee (Pennell et al., 2008). A mix of paper and pencil and computer administration 119 
procedures was used, with low/middle income countries more likely than high income 120 
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countries to use paper and pencil administration. Informed consent was obtained in all 121 
countries before beginning interviews. Local Institutional Review Boards approved and 122 
monitored the procedures used to protect human subjects.  123 
 Diagnostic assessment: DSM-IV disorders were assessed with Version 3.0 of the 124 
WHO Composite International Diagnostic Interview (CIDI; Kessler & Üstün, 2004), a fully-125 
structured diagnostic interview designed to be administered by trained lay interviewers.  126 
Disorders were assessed using the definitions of the American Psychiatric Association DSM-127 
IV (APA, 1994). The disorders assessed included mood disorders (major depressive disorder, 128 
dysthymic disorder, bipolar disorder), anxiety disorders (panic disorder, generalized anxiety 129 
disorder, agoraphobia without panic disorder, social phobia, specific phobia, separation 130 
anxiety disorder, post-traumatic stress disorder), externalizing disorders (attention-131 
deficit/hyperactivity disorder, conduct disorder, intermittent explosive disorder, oppositional-132 
defiant disorder), and substance disorders (alcohol and illicit drug abuse with or without 133 
dependence). DSM-IV organic exclusion rules were used to make diagnoses. Methodological 134 
evidence collected in clinical reappraisal studies shows that diagnoses based on CIDI 3.0 135 
have generally good concordance with diagnoses based on blinded clinical reappraisal 136 
interviews (Kessler et al., 2005; Haro et al., 2006). This study only included respondents with 137 
a diagnosed disorder. 138 
 Disorder severity: Twelve-month DSM-IV/CIDI disorders were classified as severe, 139 
moderate or mild. Respondents were classified as having a severe 12-month disorder if they 140 
met criteria for bipolar I disorder, substance dependence with a physiological dependence 141 
syndrome, had a suicide attempt in the past 12 months in conjunction with any 12-month 142 
disorder, or if they had at least one 12-month disorder associated with self-reported severe 143 
role impairment as assessed with the Sheehan Disability Scale (SDS; Sheehan, Harnett-144 
Sheehan, & Raj, 1996). Respondents not classified as having a severe disorder were classified 145 
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as moderate if interference was rated as at least moderate in any SDS domain or if the 146 
respondent had substance dependence without a physiological dependence syndrome. The 147 
remaining respondents with any 12-month disorder were categorized as mild.  148 
 Treatment: All Part II respondents were asked whether they ever received treatment 149 
for “problems with your emotions or nerves or your use of alcohol or drugs." Both outpatient 150 
and inpatient treatment are included in the results, as the surveys do not distinguish between 151 
treatment settings for each episode of care. Separate assessments were made for different 152 
types of professionals, support groups, self-help groups, mental health crisis hotlines, and 153 
complementary-alternative medicine (CAM) therapies.  154 
Reports of 12-month treatment were classified into three mutually exclusive 155 
categories: treatment by a psychiatrist whether or not treatment was also received from some 156 
other healthcare professional; treatment by other mental health professional in the absence of 157 
psychiatric treatment; and treatment in the general medical sector only. This classification 158 
focuses on the level of specialization of the care required by the patient, which is tied to 159 
increased costs and complexity of the care delivered. Hence, disorder severity indicates the 160 
need, while the type of services used (as defined above) provides an initial breakdown of the 161 
system’s resources. Of note, we are not comparing between different providers (in fact, those 162 
receiving care from a psychiatrist may also receive care from a psychologist and a general 163 
physician), but between levels in a stepped care model that meets increased need with 164 
increasingly resource-intensive services. 165 
Treatment dropout: Respondents who received treatment in each healthcare 166 
treatment sector in the past 12 months were asked whether treatment had stopped or was 167 
ongoing. Respondents that reported they stopped treatment in the healthcare sector were 168 
asked whether they “quit before the [provider(s) in that sector] wanted [them] to stop”. 169 
Respondents who reported quitting before the provider(s) wanted them to stop were classified 170 
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as having dropped out from that treatment sector. For purposes of these analyses overall 171 
dropout denotes dropping out of all studied healthcare sectors. Further, we distinguished 172 
whether dropout occurs during the first two encounters (i.e., early), or after the third (i.e., 173 
late). This distinction is consistent with an important clinical consideration: it may take more 174 
than one encounter for the patient to sufficiently engage with a provider in order to move to 175 
the next stage of care. And, we posit that three or more encounters may indicate that the 176 
treatment stage was achieved. We acknowledge that this threshold is to some extent arbitrary, 177 
so our findings with this respect should be interpreted with caution. 178 
Predictors: All respondents were asked about health insurance. Responses were 179 
classified into the categories state-funded or subsidized, insurance through an employer or 180 
national social security, direct private/optional insurance, any other health insurance, and 181 
none. Socio-demographic predictors included gender, age (18-29, 30-44, 45-59, 60+), 182 
education and family income (each coded low, low-average, high-average, high), and marital 183 
status (married/cohabiting, previously married, never married). Given the wide cross-national 184 
variation in education, the four categories of educational attainment were coded to be 185 
appropriate for the specific country. In high-income countries, the high education category 186 
corresponds to a college degree, high-average to some post-secondary education without a 187 
college degree, low-average to secondary school graduation, and low to less than secondary 188 
education. These thresholds divide the populations of high-income countries into four groups 189 
of roughly equal size. The thresholds in other countries were selected to do the same. For 190 
family income, we classified high income as greater than three times the within-country 191 
median per capita family income (i.e. income divided by number of family members), high-192 
average income as between one and three times than median, low-average as 50–100% of 193 
that median, and low income as less than 50% median per capita family income. 194 
Analysis methods 195 
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All analyses were carried out using SAS Version 9.4 (SAS Institute Inc., 2002). 196 
Cross-tabulations were used to examine the distribution of treatment and dropout rates across 197 
sectors. The timing of dropout was examined using Kaplan-Meier curves. Predictors of 198 
dropout were examined with survival analysis using a logistic link function. Survival 199 
coefficients and these coefficients +/- two standard errors were exponentiated and reported as 200 
odds-ratios (ORs) with 95% confidence intervals (CIs). Separate models were examined for 201 
early and later dropout. Standard errors of estimates were obtained using the SUDAAN 202 
(SUDAAN 8.0, 2002) software system to adjust for the geographic clustering and weighting 203 
of the WMH data. Multivariate significance tests were made using Wald χ2 tests based on 204 
coefficient variance–covariance matrices adjusted for design effects using the Taylor series 205 
method. Statistical significance was evaluated using two-sided design-based tests (α=.05). 206 
Results 207 
 The distribution of treatment across providers was similar in high-income and 208 
low/middle-income countries, with 30.8-32.9% of patients, respectively, treated by a 209 
psychiatrist, 22.2-19.4% by other mental health professions but not psychiatrists, and the 210 
remaining 47.0-47.7% treated exclusively in the general medical sector (Table 2). Mean 211 
(interquartile range) number of visits (across all sectors) in high- and low/middle-income 212 
countries was consistently highest among patients seen by psychiatrists (18.4 [3-21], 13.6 [2-213 
12]), intermediate among patients seen by other mental health professionals (13.5 [2-15], 6.2 214 
[1-6]), and lowest among patients seen exclusively in the general medical sector (3.0 [1-2], 215 
2.9 [1-3]).  216 
(Table 2 and Figure 1 about here) 217 
The treatment dropout rate was lowest in both high- and low/middle-income countries 218 
among patients treated by a psychiatrist (17.2-18.5%), intermediate among those treated by 219 
other mental health professions (19.9-44.2%), and highest among those treated exclusively in 220 
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the general medical sector (43.2-57.2%) (Table 2). However, these were all lower-bound 221 
estimates because the number of patients still in treatment at the time of interview was 222 
consistently higher than the number who reported successfully completing treatment, raising 223 
the likelihood that some of these patients dropped out of treatment subsequent to the time of 224 
interview. An estimate of these cumulative dropout rates was obtained by generating Kaplan-225 
Meier curves based on retrospective data of conditional probabilities of dropout as a function 226 
of number of visits (Figure 1). Projected cumulative dropout was estimated to be close to 227 
30% overall after 13 visits (the largest number for visits over which stable estimates of 228 
cumulative dropout could be projected) in high-income countries and approximately 45% in 229 
low/middle-income countries. Projected dropout rates varied from values close to 15% for 230 
specialty treatment to nearly 50% for general medical treatment in high-income countries and 231 
from 25% for psychiatry treatment to 50% for other mental health specialty treatment and 232 
60% for general medical treatment in low/middle-income countries. The majority of 233 
projected dropouts in each curve occurred within two visits. This was especially pronounced 234 
among patients seen exclusively in the general medical sector, where well over 90% of all 235 
projected dropout occurred after one or two visits. 236 
(Table 3 about here) 237 
Predictors of treatment dropout 238 
 Severity and disorder type: Models were estimated separately for dropout after “1 or 239 
2” and “3 or more”. The severity of the clinical presentation for respondents with any 240 
disorder was a significant predictor in a number of models (Table 3). For both low- and high-241 
income countries, dropout was significantly elevated among patients with mild (OR = 1.8) 242 
and moderate (OR = 1.5) disorders after 1-2 visits. In high-income countries, these increased 243 
odds were driven by early dropout from psychiatric treatment. The associations of severity 244 
and dropout in low/middle-income countries were diverse and more nuanced. In addition to 245 
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the increased early dropout of people with less severe presentations (also driven by increased 246 
dropout from treatment with psychiatrists; OR = 2.2 for mild and 4.7 for moderate), we found 247 
a significant association of severity with dropout after 3 or more visits. The direction of these 248 
associations was contingent on the type of treatment provided: people with milder clinical 249 
presentations had elevated odds of dropout from treatment with a psychiatrist after 3 or more 250 
visits (OR = 2.2 for mild and OR=1.9 for moderate), whereas people with severe 251 
presentations that were not seeing a psychiatrist had decreased dropout after 3 or more visits 252 
(OR = 0.5-0.4 for moderate in “other mental health service” and “general medical” 253 
respectively). No consistent associations were found involving disorder type (see Appendix 254 
Table 1), and the small numbers of respondents with some specific disorders and disorder 255 
combinations precluded us from estimating more complex models combining disorder type, 256 
number, and severity.  257 
(Table 4 about here) 258 
Insurance: Patients with no coverage (either in the form of insurance or public 259 
mental health services) in high-income countries were significantly more likely to drop out 260 
from psychiatric care after 3+ visits than patients who did have insurance (Table 4). This was 261 
true regardless of the type of insurance the patient carried (see Appendix Table 2). The same 262 
general pattern for dropout from psychiatric treatment was found in low/middle-income 263 
countries (i.e., higher dropout after 3+ visits among patients with no insurance with than with 264 
insurance), and this association was also significant for those seeking treatment by other 265 
mental health providers.  Patients with no insurance in low- and middle-income countries are 266 
significantly less likely to drop out after 1-2 visits if they sought help only in the general 267 
medical sector.  268 
Socio-demographics: The socio-demographic variables considered here had 269 
generally non-significant multivariate associations with treatment dropout in the 16 270 
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multivariate models estimated across sectors crossed by number of visits separately in 271 
low/middle- and high-income countries after controlling for type-severity of disorders and 272 
type of insurance. Summary multivariate results are reported in Appendix Table 3. Perhaps 273 
the most striking result is that the indicators of socio-economic status (education, 274 
employment, family income) are for the most part unrelated to dropout.  275 
Conclusion and Discussion 276 
These findings indicate that dropout during treatment for mental disorders is high, 277 
reaching nearly 30% in high-income and 45% in low-income countries. Dropout is higher in 278 
general medical rather than in specialist settings (nearly 60% vs 20% in lower income 279 
settings), and higher for mild and moderate than for severe presentations. We also found that 280 
the lack of financial protection for mental health services is associated with overall increased 281 
dropout from specialist care, as well as with increased relative dropout rates for people with 282 
milder clinical forms from psychiatric care, and for people with more severe presentations 283 
from general medical services, especially in low-income settings.  284 
The results of this study need to be assessed taking into consideration the following 285 
limitations. First, data are based on self-report which is susceptible to recall bias. Second, 286 
data do not indicate if visits in the previous 12 months correspond to a single episode of care, 287 
or if the treatment from two or more professionals occurred within an interdisciplinary care 288 
system. In case of visits being conducted by more than one professional, this would 289 
underestimate dropout rate. Third, there is heterogeneity across the countries in disorder 290 
prevalence (Demyttenaere et al., 2004), health system service organization and resources 291 
(WHO, 2017) that may affect the conclusions based on pooled analyses, which was necessary 292 
to avoid sparse data. Analysis by country income level and inclusion of a variable to capture 293 
financial protection through insurance or public services, seek to mitigate this limitation. 294 
Fourth, community surveys fail to adequately capture low prevalence disorders (such as 295 
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schizophrenia) due to methodological constraints; most respondents with these disorders 296 
though, can be expected to meet criteria for comorbid anxiety, mood, or substance disorders, 297 
and would therefore be indirectly captured in our analyses. Fifth, our analysis focuses on 298 
dropout from treatments provided within the healthcare system, and does not consider 299 
community supports provided through community-based human services, CAM, and support 300 
groups. Sixth, we highlight that the number of visits does not imply a consistent interval of 301 
time. One advantage of the application of discrete-time survival analysis models is that it 302 
does not require an x-axis related to time (which would be continuous) and also allows 303 
inconsistent time intervals. Similar approaches in which Kaplan–Meier curves were used to 304 
examine drop out by number of visits have been published before in the area (see e.g. Edlund 305 
et al., 2002; Olfson et al., 2009; Wells et al., 2013). Seventh, we also acknowledge that we 306 
are not able to attribute each episode of care to specific diagnoses. However, mental health 307 
providers are expected to treat people as a whole, so it is reasonable to expect that disorders 308 
that meet well-established thresholds (such as CIDI diagnosed disorders) would be captured 309 
by a clinical assessment performed within the healthcare system. Finally, several country-310 
specific socioeconomic and cultural characteristics may explain variations in help-seeking 311 
behaviors: we have shown the impact of financial coverage on dropout rates, but also stigma 312 
toward mental illness and other cultural norms may affect people’s ability to seek and remain 313 
engaged care, and would be important areas of additional research. 314 
Despite these limitations, our results have important implications for mental health 315 
policy and systems planning. In addition to the findings summarized above, our data indicate 316 
that the impact of sociodemographic variables on dropout rates is not significant. This may 317 
signal that dropout is not so much a consequence of predisposing population characteristics 318 
but of how the healthcare system is resourced and organized, or of how treatment is perceived 319 
in terms of effectiveness (Andersen, 1995). This is consistent with a previous report of the 320 
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WMH Surveys Initiative (Evans-Lacko et al., 2018), and provides targets for improvement 321 
that are within the health system itself (as opposed to socially pre-determined individual 322 
variables). 323 
Dropout generally occurs during the first two visits of care, most likely before 324 
beneficial effects of treatment can be produced and perceived by the individual. This is 325 
especially true of general medical services, where 90% of dropouts occur before the third 326 
session. This is consistent with previous epidemiological and administrative data studies 327 
(Olfson et al., 2009; Pan, Liu, & Yeh, 2013; Wells et al., 2013; Petterson, Miller, Payne-328 
Murphy, & Phillips, 2014), and highlights the need to improve training, supervision, support 329 
and to review treatment practices for general health providers if they are to be effective entry 330 
points to the mental health system. Indeed, patterns of dropout varied remarkably between 331 
professionals and country income level. Mean number of visits was higher and dropout rates 332 
lower (more than 10 visits and less than 20% dropout rates) for psychiatrists across country 333 
income levels. Figures were similar for the “other health professionals” group in high-income 334 
countries. However, the figures were very different (3 to 6 mean number of visits and 43 to 335 
57% dropout rates) for the general medical sector across country income levels or for those 336 
treated by other mental health professionals in low/middle-income countries. Given that 337 
current guidelines call for common mental disorders to be treated in primary care (NICE, 338 
2004; Fletcher et al., 2009), our findings indicate that significant efforts remain to be made 339 
before the general medical sector can provide adequate mental care: most people actually 340 
drop out before reaching the minimum required number of visits by any standard (NICE, 341 
2009; APA, 2010; Gautam, Jain, Gautam, Vahia, & Grover, 2017). 342 
Our findings also indicate that dropout is significantly associated with severity but not 343 
with disorder type. Previous studies have been inconsistent: Simon and Ludman found an 344 
association in patients with depression between severity and dropout rates (Simon & 345 
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Ludman, 2010; Pan et al., 2013), while Warden et al. did not (Warden et al., 2009a, 2009b). 346 
With respect to specific mental disorders, some studies found variability in dropout rates 347 
(Murphy et al., 2015; Oflaz et al., 2015; Fernandez-Arias et al., 2016), while others did not 348 
(Gonzalez, Weersing, Warnic, Scahill, & Woolston, 2011). The granularity of our data allows 349 
us to go one step further and draw preliminary conclusions that shed light on these 350 
inconsistencies. In general, people with milder presentations tend to drop out more and drop 351 
out earlier, but this tendency is mostly driven by dropout of treatment with psychiatrists. Data 352 
from lower income settings show that, in addition to this increased dropout of people with 353 
milder clinical presentations from psychiatric care, there is an increase in dropout of people 354 
with more severe presentations from general medical and other mental health services. This 355 
finding is relevant for health systems planning because it points to what may be the specific 356 
changes required to improve outcomes. Indeed, best practices prescribe the management of 357 
common and milder mental disorders through primary care, while reserving the scarce 358 
specialist resources for more severe clinical presentations and for supervision of general 359 
medical services. Our data indicate that in low- and middle-income settings, there may be 360 
inefficiencies and potential quality gaps in how the system is organized: a subgroup of people 361 
with milder clinical presentations are receiving care from psychiatrists (and dropping out 362 
more than people with severe disorders), while a subgroup of people with more severe 363 
clinical forms are not receiving care from psychiatrists (and dropping out more than people 364 
with less severe disorders). Hence, a stepped care framework in which milder forms are dealt 365 
with directly through general medical services while severe cases are systematically referred 366 
to psychiatrists or managed in closer consultations with specialists seems like a promising 367 
evidence-based approach. 368 
Finally, these results show a significant effect of financial coverage of health services 369 
(in the form of insurance or direct public provision) on dropout rates. Insurance was 370 
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associated with lower dropout rates after the third visit in patients being treated by 371 
psychiatrists both in high-income and low/middle-income countries. In low/middle-income 372 
countries, insurance was associated with lower dropout rates in treatment with other mental 373 
health professionals as well. Previous studies (which were constrained to the mental health 374 
sector and/or were not stratified by service provider) have also found an effect of insurance 375 
on dropout rates (Warden et al., 2009b; Agarwal, Pan, & Sambamorthi, 2013). Our granular 376 
data highlight the impact of financial protection on the continuity of care at different level of 377 
specialization both in low- and high-income settings.  378 
Collectively these findings have implications for policy and health systems planning. 379 
First, dropout from mental health treatment is relevant globally because of its high frequency, 380 
its potential to increase health care costs due to inefficiencies, and to worsen health outcomes 381 
due to missed opportunities to intervene early (Barnicot, Katsakou, Marougka, & Priebe, 382 
2011; Swift & Greenberg, 2012). Second, extending financial protection and coverage for 383 
mental disorders may reduce dropout and therefore improve continuity of care and health 384 
outcomes, especially for those that need specialist care. Third, dropout seems to affect diverse 385 
subgroups differently, and a holistic, stepped-care approach to providing mental health 386 
services can be expected to improve efficiency and quality of care by: (a) grounding the entry 387 
point to the mental health system in primary care, which should manage milder clinical 388 
presentations; (b) providing adequate training, support and specialist supervision for non-389 
specialists; and (c) streamlining referral to psychiatrists for more severe and complex cases.390 
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Table 1.  WMH sample characteristics by World Bank income categoriesa 
  
 
  
Sample 
size   
 
Country by income category Surveyb Sample characteristicsc 
Field 
dates 
Age 
range Part I Part II 
Part II and age 
≤ 44d 
Response 
ratee 
I. Low and middle income countries 
      
Brazil - São Paulo São Paulo Megacity São Paulo metropolitan area. 2005-8 18-93 5,037 2,942 -- 81.3 
Bulgaria NSHS Nationally representative. 2002-6 18-98 5,318 2,233 741 72.0 
Colombia NSMH 
All urban areas of the country (approximately 73% of the total national 
population). 
2003 18-65 4,426 2,381 1,731 87.7 
Colombia - Medellinh MMHHS Medellin metropolitan area 2011-12 19-65 3,261 1,673  97.2 
Iraq IMHS Nationally representative. 2006-7 18-96 4,332 4,332 -- 95.2 
Lebanon LEBANON Nationally representative. 2002-3 18-94 2,857 1,031 595 70.0 
Mexico M-NCS 
All urban areas of the country (approximately 75% of the total national 
population).  
2001-2 18-65 5,782 2,362 1,736 76.6 
Nigeria NSMHW 
21 of the 36 states in the country, representing 57% of the national 
population. The surveys were conducted in Yoruba, Igbo, Hausa and 
Efik languages.  
2002-4 18-100 6,752 2,143 1,203 79.3 
Peru EMSMP 
Five urban areas of the country (approximately 38% of the total 
national population). 
2004-5 18-65 3,930 1,801 1,287 90.2 
PRCf  - Shenzheng Shenzhen 
Shenzhen metropolitan area. Included temporary residents as well as 
household residents. 
2005-7 18-88 7,132 2,475 -- 80.0 
Romania RMHS Nationally representative. 2005-6 18-96 2,357 2,357 -- 70.9 
South Africag SASH Nationally representative. 2002-4 18-92 4,315 4,315 -- 87.1 
Ukraine CMDPSD Nationally representative. 2002 18-91 4,725 1,720 541 78.3 
TOTAL     (60,224) (31,765) (7,834) 81.1 
II. High-income countries       
Argentina AMHES 
Eight largest urban areas of the country (approximately 50% of the 
total national population) 
2015 18-98 3,927 2,116 -- 77.3 
Belgium ESEMeD 
Nationally representative. The sample was selected from a national 
register of Belgium residents. 
2001-2 18-95 2,419 1,043 486 50.6 
France ESEMeD 
Nationally representative. The sample was selected from a national 
list of households with listed telephone numbers.  
2001-2 18-97 2,894 1,436 727 45.9 
Germany ESEMeD Nationally representative.  2002-3 19-95 3,555 1,323 621 57.8 
Israel NHS Nationally representative. 2003-4 21-98 4,859 4,859 -- 72.6 
Italy ESEMeD 
Nationally representative. The sample was selected from municipality 
resident registries. 
2001-2 18-100 4,712 1,779 853 71.3 
Japan WMHJ 2002-2006 Eleven metropolitan areas.  2002-6 20-98 4,129 1,682 -- 55.1 
Netherlands ESEMeD 
Nationally representative. The sample was selected from municipal 
postal registries. 2002-3 18-95 2,372 1,094 516 56.4 
New Zealandg NZMHS Nationally representative. 2004-5 18-98 12,790 7,312 -- 73.3 
N. Ireland NISHS Nationally representative. 2005-8 18-97 4,340 1,986 -- 68.4 
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Table 1 continued.  WMH sample characteristics by World Bank income categoriesa 
 
  
  
Sample 
size   
 
Country by income category Surveyb Sample characteristicsc 
Field 
dates 
Age 
range Part I Part II 
Part II and age 
≤ 44d 
Response 
ratee 
Poland EZOP Nationally representative 2010-11 18-65 10,081 4,000 2,276 50.4 
Portugal NMHS Nationally representative. 2008-9 18-81 3,849 2,060 1,070 57.3 
Spain ESEMeD Nationally representative. 2001-2 18-98 5,473 2,121 960 78.6 
Spain - Murcia PEGASUS- Murcia Murcia region. Regionally representative.  2010-12 18-96 2,621 1,459 -- 67.4 
United States NCS-R Nationally representative. 2001-3 18-99 9,282 5,692 3,197 70.9 
TOTAL     (77,303) (39,962) (10,706) 63.5 
III. TOTAL     (137,527) (71,727) (18,540) 70.2 
 
aThe World Bank (2012) Data. Accessed May 12, 2012 at: http://data.worldbank.org/country. Some of the WMH countries have moved into new income categories since the surveys were conducted. 
The income groupings above reflect the status of each country at the time of data collection. The current income category of each country is available at the preceding URL. 
bNSMH (The Colombian National Study of Mental Health); IMHS (Iraq Mental Health Survey); NSMHW (The Nigerian Survey of Mental Health and Wellbeing); EMSMP (La Encuesta Mundial de Salud 
Mental en el Peru); CMDPSD (Comorbid Mental Disorders during Periods of Social Disruption); NSHS (Bulgaria National Survey of Health and Stress); MMHHS (Medellín Mental Health Household 
Study); LEBANON (Lebanese Evaluation of the Burden of Ailments and Needs of the Nation); M-NCS (The Mexico National Comorbidity Survey); RMHS (Romania Mental Health Survey); SASH 
(South Africa Health Survey); AMHES (Argentina Mental Health Epidemiologic Survey); ESEMeD (The European Study Of The Epidemiology Of Mental Disorders); NHS (Israel National Health 
Survey); WMHJ2002-2006 (World Mental Health Japan Survey); NZMHS (New Zealand Mental Health Survey); NISHS (Northern Ireland Study of Health and Stress); EZOP (Epidemiology of Mental 
Disorders and Access to Care Survey); NMHS (Portugal National Mental Health Survey); PEGASUS-Murcia (Psychiatric Enquiry to General Population in Southeast Spain-Murcia);NCS-R (The US 
National Comorbidity Survey Replication).    
cMost WMH surveys are based on stratified multistage clustered area probability household samples in which samples of areas equivalent to counties or municipalities in the US were selected in the 
first stage followed by one or more subsequent stages of geographic sampling (e.g., towns within counties, blocks within towns, households within blocks) to arrive at a sample of households, in each 
of which a listing of household members was created and one or two people were selected from this listing to be interviewed. No substitution was allowed when the originally sampled household 
resident could not be interviewed. These household samples were selected from Census area data in all countries other than France (where telephone directories were used to select households) and 
the Netherlands (where postal registries were used to select households). Several WMH surveys (Belgium, Germany, Italy, Poland, Spain-Murcia) used municipal, country resident or universal health-
care registries to select respondents without listing households. The Japanese sample is the only totally un-clustered sample, with households randomly selected in each of the 11 metropolitan areas 
and one random respondent selected in each sample household. 18 of the 28 surveys are based on nationally representative household samples.     
dArgentina, Brazil, Colombia-Medellin, Iraq, Israel, Japan, New Zealand, Northern Ireland, PRC - Shenzhen, Romania, South Africa  and Spain-Murcia did not have an age restricted Part 2 sample. All 
other countries, with the exception of Nigeria and Ukraine (which were age restricted to ≤ 39) were age restricted to ≤ 44. 
eThe response rate is calculated as the ratio of the number of households in which an interview was completed to the number of households originally sampled, excluding from the denominator 
households known not to be eligible either because of being vacant at the time of initial contact or because the residents were unable to speak the designated languages of the survey. The weighted 
average response rate is 70.2%. 
f People’s Republic of China 
g For the purposes of cross-national comparisons we limit the sample to those 18+. 
hColombia moved from the "lower and lower-middle income" to the "upper-middle income" category between 2003 (when the Colombian National Study of Mental Health was conducted) and 2010 
(when the Medellin Mental Health Household Study was conducted), hence Colombia's appearance in both income categories. For more information, please see footnote a. 
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Table 2. Number of visits by sector (Part I) and treatment status (Part II) and by treatment among respondents with at least one disorder in the 12 months before interview who received mental 
health treatment in the past 12 months in the the World Mental Health Surveys, by country income group 
Part I 
 High-income countries  Low-middle income countries 
 n
a % b (SE) 
Mean number of 
visits (SE) IQRc 
 
na % b (SE) 
Mean number 
of visits (SE) IQRc 
Treatment              
Psychiatrist (whether or not received other service) 1197 30.8  (0.9) 18.4 (1.0) [3, 21] 
 
395 32.9  (1.5) 13.6  (0.9) [2, 12] 
Not psychiatrist but other mental health (whether or 
not received general medical) 828 22.2  (0.8) 13.5 (0.5) [2, 15] 
 
235 19.4  (1.2) 
6.2  
(0.4) [1, 6] 
General medical (only) 1762 47.0  (1.0) 3.0 (0.1) [1, 2] 
 
573 47.7  (1.7) 2.9  (0.1) [1, 3] 
                
Any of the 3 services 3787    10.1  (0.4) [1, 10]   1203   7.0  (0.4) [1, 5] 
Part II 
 High-income countries  Low-middle income countries 
 Treatment drop out   
Completed 
treatment   Still in treatment  Treatment drop out   Completed treatment   Still in treatment 
 n
a %b (SE)   na %b (SE)   na %b (SE)  n
a %b (SE)   na %b (SE)   n
a %b (SE) 
Treatment                                         
Psychiatrist (whether or not received other service) 174 17.2 1.2   110 9.6 0.8   913 73.2 1.4 
 
84 18.5 1.6   55 16.5 1.8   256 65.0 2.0 
Not psychiatrist but other mental health (whether or 
not received General Medical) 150 19.9 1.5 
  
160 19.2 1.2 
  
518 60.9 1.6 
 
106 44.2 3.0 
  
37 16.9 2.5 
  92 38.9 2.9 
General medical (only) 784 43.2 1.2   284 17.4 1.1   694 39.5 1.3 
 
308 57.2 1.9   95 17.6 1.3   170 25.2 1.9 
                                          
Any of the 3 services 1108    554    2125    498    187    518     
 
aUnweighted number of respondents who received treatment in the sector.   
bWeighted percentage. Percentages are weighted to adjust for differences in selection probabilities, differential non-response, oversampling of Part II cases and residual differences on sociodemographic 
variables between the sample and the population. 
cIQR: Interquartile range... 
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Table 3. Bivariate associations of 12-month disorder severity with treatment dropout after 1-2 and 3+ visits among patients with 12-month DSM-IV/CIDI disorders in the World Mental 
Health Surveys, by country income group1 
 1-2 visits 3+ visits - OR (95% CI) 
 Mild Moderate   Mild Moderate   
I. High income countries OR 95% CI OR 95% CI 
22  
(p-value) 
Sample 
size OR 95% CI OR 95% CI 
22  
(p-value) 
Sample 
size 
Psychiatrist (whether or not received other service) 1.8  (0.9-3.4) 2.4*  (1.4-4.2) 0.007 225 2.2  (1.0-4.6) 1.2  (0.7-2.0) 0.115 972 
Not psychiatrist but other mental health (whether or not received general medical) 1.0  (0.5-1.9) 0.8  (0.4-1.4) 0.665 195 0.9  (0.3-2.3) 1.2  (0.7-1.9) 0.693 633 
General medical (only) 1.4  (1.0-1.8) 1.1  (0.9-1.4) 0.083 1319 0.9  (0.4-2.1) 0.7  (0.4-1.3) 0.566 443 
Any of the three services 1.8*  (1.4- 2.2) 1.5*  (1.2-1.9) <.0001 1739 1.6  (0.9-2.8) 1.5*  (1.0-2.1) 0.049 2048 
II. Low-Middle income countries           
Psychiatrist (whether or not received other service) 2.2*  (1.2-4.1) 4.7*  (2.4-8.9) <.0001 126 2.2*  (1.4-3.7) 1.9  (0.5-6.7) 0.005 269 
Not psychiatrist but other mental health (whether or not received general medical) 1.7  (0.8-3.5) 1.8*  (1.0-3.0) 0.111 132 0.8  (0.5-1.4) 0.5*  (0.3-0.8) 0.001 103 
General medical (only) 0.9  (0.5-1.5) 0.9  (0.6-1.3) 0.833 399 0.8  (0.5-1.2) 0.4*  (0.3-0.6) <.0001 174 
Any of the three services 1.8*  (1.2-2.5) 1.8*  (1.4-2.4) 0.000 657 2.9*  (2.1-4.0) 1.5  (0.9-2.5) <.0001 546 
             
*Significant at the .05 level, two-sided test compared to patients with severe disorders 
1Each model included dummy variable controls for survey and number of visits. The models for any dropout additionally controlled for treatment sector.  
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Table 4. Bivariate associations1 of health insurance with treatment dropout (after 1-2 and 3+ visits) among patients with 12-month DSM-IV/CIDI 
in the World Mental Health Surveys disorders in the WMH surveys, by country income group 
 No insurance     
 OR 95% CI 
  21 (p-value) 
 Sample size 
I. High income countries       
After 1-2 visits       
Psychiatrist (whether or not received other service) 1.7  (0.7-4.4)  0.230  225 
Not psychiatrist but other mental health (whether or not received general medical) 1.6  (0.5-4.6)  0.395  195 
General medical (only) 1.1  (0.7-1.9)  0.677  1319 
Any of the three services 1.4  (0.9-2.1)  0.131  1739 
After 3+ visits   
 
 
 
 
Psychiatrist (whether or not received other service) 6.0*  (2.3-15.3) 
 
0.000 
 
972 
Not psychiatrist but other mental health (whether or not received general medical) 0.4  (0.1-2.1) 
 
0.271 
 
633 
General medical (only) 1.1  (0.2-6.4)  0.901  443 
Any of the three services 2.0  (0.8-4.6)  0.122  2048 
II. Low-Middle income countries   
 
 
 
 
After 1-2 visits   
 
 
 
 
Psychiatrist (whether or not received other service) 1.2  (0.7-2.2)  0.518  126 
Not psychiatrist but other mental health (whether or not received general medical) 0.8  (0.4-1.4)  0.418  132 
General medical (only) 0.4*  (0.2-0.6)  <.0001  399 
Any of the three services 0.7  (0.5-1.2)  0.218  657 
After 3+ visits   
 
 
 
 
Psychiatrist (whether or not received other service) 7.5*  (4.0-14.1) 
 
<.0001 
 
269 
Not psychiatrist but other mental health (whether or not received general medical) 11.9*  (7.4-18.9) 
 
<.0001 
 
103 
General medical (only) 1.1  (0.5-2.3) 
 
0.854 
 
174 
Any of the three services 2.9*  (1.8-4.8)  <.0001  546 
       
*Significant at the .05 level, two-sided test compared to patients with any insurance 
1Each model included dummy variable controls for survey and number of visits. The models for any dropout additionally controlled for treatment sector.
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Figure 1. 
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Appendix table 1. Bivariate analysesa of the association of mental disorder diagnosis with treatment drop out within each country income group among World 
Mental Health Survey respondents with at least one disorder in the 12 months before interview and received mental health treatment. Results for any of the three 
servicesb, stratified by number of visit 
    
 High income countries  Low-Middle income countries 
 
1-2 visits 
n=1739  
3+ visits 
n=2048  
1-2 visits 
n=657  
3+ visits 
n=546 
 
OR (95% CI) 2 (p-value)  OR  (95% CI) 2 (p-value)  OR  (95% CI) 2 (p-value)  OR  (95% CI) 2 (p-value) 
Disorder typec                
Any anxietyd 1.2 (0.9-1.4) 0.195  0.9  (0.6-1.3) 0.672  1.2  (0.9-1.6) 0.252  0.4***  (0.2-0.6) <.0001 
Any moode 0.8* (0.7-1.0) 0.032  0.6**  (0.4-0.9) 0.009  0.8  (0.6-1.1) 0.145  1.5*  (1.1-2.0) 0.011 
Any substancef 0.7 (0.5-1.0) 0.077  1.4  (1.0-2.1) 0.063  0.6*  (0.4-1.0) 0.049  2.7***  (1.6-4.5) 0.000 
Any impulseg 1.0 (0.7-1.5) 0.974  0.7  (0.4-1.2) 0.144  0.7  (0.5-1.1) 0.102  0.9  (0.4-1.8) 0.737 
Panic disorder 0.8 (0.7-1.1) 0.184  0.4**  (0.2-0.7) 0.001  0.8  (0.6-1.2) 0.277  0.1***  (0.0-0.3) 0.000 
Generalized anxiety disorder 0.9 (0.7-1.1) 0.364  0.8  (0.6-1.2) 0.374  1.0  (0.7-1.3) 0.787  0.2***  (0.1-0.4) <.0001 
Social phobia 0.8 (0.7-1.0) 0.098 
 
0.8  (0.5-1.2) 0.277 
 
1.0  (0.8-1.4) 0.799 
 
0.8  (0.5-1.3) 0.405 
Specific phobia 1.3** (1.1-1.5) 0.003 
 
0.5** (0.3-0.8) 0.009 
 
1.2  (0.8-1.6) 0.340 
 
0.8  (0.4-1.7) 0.559 
Agoraphobia 0.6* (0.5-0.9) 0.010 
 
0.6*  (0.3-1.0) 0.044 
 
0.7  (0.5-1.1) 0.122 
 
0.5**  (0.3-0.8) 0.002 
PTSD 0.7* (0.6-1.0) 0.040  1.2  (0.8-1.8) 0.353  1.1  (0.7-1.7) 0.823  0.6  (0.3-1.3) 0.192 
Separation anxiety 1.3 (0.8-2.0) 0.342  0.3  (0.1-1.1) 0.075  0.8  (0.5-1.4) 0.532  0.5  (0.1-1.7) 0.266 
Major depressive episode 0.8* (0.6-0.9) 0.014  0.7*  (0.5-0.9) 0.021  0.8  (0.6-1.1) 0.142  1.4* (1.1-1.9) 0.014 
Bipolar disorder 0.9 (0.6-1.1) 0.293  0.7  (0.5-1.2) 0.240  0.8  (0.4-1.4) 0.392  1.6  (0.5-5.2) 0.469 
Oppositional defiant disorder 0.6 (0.2-1.4) 0.232  1.4  (0.4-5.0) 0.619  0.2  (0.0-1.2) 0.079  1.1  (0.3-4.5) 0.844 
Conduct disorder 0.4 (0.1-1.7) 0.201  0.2***  (0.1-0.3) <.0001  1.7  (0.6-5.2) 0.315  1.6  (0.2-14.3) 0.658 
Attention deficit disorder 1.1 (0.6-1.9) 0.724  0.6  (0.2-1.7) 0.340  1.9  (0.8-4.6) 0.127  <0.1***  (<0.1-<0.1) <.0001 
Intermitent explosive disorder 1.2 (0.8-1.8) 0.345  0.7  (0.3-1.4) 0.286  0.6*  (0.4-0.9) 0.018  0.9  (0.4-2.0) 0.771 
Alcohol abuse 0.8 (0.5-1.2) 0.218  1.4  (0.8-2.3) 0.196  0.7  (0.4-1.3) 0.263  2.9***  (1.7-5.1) 0.000 
Alcohol dependence 0.6 (0.4-1.0) 0.076 
 
1.0  (0.5-1.9) 0.987 
 
0.5  (0.2-1.0) 0.057 
 
1.9  (0.8-4.7) 0.145 
Drug abuse 0.8 (0.5-1.4) 0.522 
 
1.8*  (1.1-3.0) 0.020 
 
0.5  (0.2-1.5) 0.188 
 
2.2*  (1.2-4.0) 0.010 
Drug dependence 0.6 (0.3-1.4) 0.261 
 
0.9  (0.5-1.4) 0.535 
 
0.8  (0.2-3.1) 0.744 
 
0.4  (0.1-1.1) 0.081 
             
aModels are bivariate and based on a discrete time survival framework with a person-visit file.  Country is also included in the model (not shown).  
bIt includes dropout from all of up to  3 different providers: Psychiatrist, Other Mental Health professional, General Medical 
cReference category is not having the disorder 
dAny anxiety disorder includes Panic Disorder, Generalized Anxiety Disorder, Social Phobia, Specific Phobia, Agoraphobia, PTSD, Social Anxiety 
eAny mood disorder includes Major Depressive Episode, Dysthymia and Bipolar Disorder 
fAny substance disorder  includes Alcohol Abuse, Alcohol Dependence, Drug Abuse, Drug Dependence 
gAny impulse control disorder includes Opositional Defiant Disorder, Conduct disorder, Attention Deficit Disorder, Intermitent Explosive Disorder 
* p<0.05 
**p<0.01 
***p<0.001
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Appendix table 2. Bivariate associations of health insurance type with treatment dropout after 1-2 and 3+ visits among patients with 12-month DSM-IV/CIDI disorders in the WMH surveys1 
       
 
State funded coverage 
or subsidized 
insurance 
Insurance through 
employment or national 
social security 
Direct 
private/optional 
insurance 
Other types of 
insurance   
 OR (95% CI) % OR (95% CI) % OR (95% CI) % OR (95% CI) % 
24  
(p-value) 
Sample 
size 
I. High income countries               
After 1-2 visits               
Psychiatrist (whether or not have received other service) 0.6 (0.1-2.8) 14.7 0.6  (0.2-1.4) 44.4 0.3  (0.1-1.1) 12.4 2.2  (0.5-9.8) 2.2 0.195 225 
Not psychiatrist but other mental health (whether or not received general medical) 0.4 (0.1-1.3) 7.7 0.8  (0.3-2.4) 34.9 0.4  (0.1-2.0) 13.3 0.5  (0.1-3.7) 1.5 0.374 195 
General medical (only) 0.7 (0.4-1.3) 9.9 1.0  (0.6-1.8) 29.6 0.8  (0.4-1.4) 13.0 1.0  (0.3-3.4) 0.9 0.550 1319 
Any of the three services 0.6 (0.4-1.1) 10.2 0.8  (0.5-1.2) 32.1 0.6*  (0.4-0.9) 13.0 1.0  (0.4-2.5) 1.2 0.080 1739 
After 3+ visits                
Psychiatrist (whether or not have received other service) 0.1* (0.0-0.6) 13.9 0.2*  (0.1-0.5) 40.4 0.2*  (0.1-0.5) 15.6 0.0*  (0.0-0.0) 1.3 <.0001 972 
Not psychiatrist but other mental health (whether or not received general medical) 2.7 (0.4-17.7) 7.9 3.8  (0.6-22.8) 31.6 1.2  (0.2-6.9) 14.2 1.0  (0.1-11.9) 1.9 0.291 633 
General medical (only) 0.9 (0.2-3.4) 7.5 0.9  (0.1-8.0) 27.3 0.9  (0.1-9.6) 13.3 --2   0.7 -- 2 443 
Any of the three services 0.4 (0.1-1.3) 10.6 0.6  (0.3-1.4) 34.9 0.5  (0.2-1.2) 14.7 0.3  (0.0-1.6) 1.4 0.502 2048 
II. Low-Middle income countries       
After 1-2 visits               
Psychiatrist (whether or not received other service) 1.1 (0.4-3.4) 18.3 0.9  (0.4-1.7) 27.0 0.5  (0.2-1.7) 9.5 -- 2  0.8 -- 2 126 
Not psychiatrist but other mental health (whether or not received general medical) 0.4 (0.1-1.1) 9.1 1.8  (0.9-3.6) 39.4 1.0  (0.4-2.8) 10.6 2.3  (1.0-5.4) 4.6 0.013 132 
General medical (only) 4.5* (2.2-9.0) 16.8 1.8  (1.0-3.4) 14.3 2.9*  (1.3-6.6) 5.5 5.1*  (1.6-16.2) 2.8 0.000 399 
Any of the three services 1.5 (0.9-2.7) 15.5 1.3  (0.7-2.1) 21.8 1.1  (0.6-2.0) 7.3 1.9  (0.6-5.5) 2.7 0.558 657 
After 3+ visits               
Psychiatrist (whether or not received other service) 0.1*  (0.0-0.3) 27.1 0.1*  (0.0-0.2) 26.0 0.2*  (0.1-0.5) 11.9 0.1  (0.0-1.4) 3.7 <.0001 269 
Not psychiatrist but other mental health (whether or not received general medical) 0.0* (0.0-0.0) 14.6 0.1*  (0.0-0.1) 27.2 0.1*  (0.0-0.1) 14.6 2.1*  (1.3-3.4) 3.9 <.0001 103 
General medical (only) 0.9 (0.5-1.5) 14.4 1.2  (0.6-2.4) 13.2 1.5  (0.3-7.1) 5.8 0.2*  (0.1-0.4) 5.2 <.0001 174 
Any of the three services 0.3* (0.2-0.6) 20.7 0.4*  (0.2-0.7) 22.2 0.4*  (0.2-0.8) 10.4 0.1*  (0.1-0.4) 4.2 <.0001 546 
               
*Significant at the .05 level, two-sided test compared to patients with no insurance 
1Each model included dummy variable controls for survey and number of visits. The models for any dropout additionally controlled for treatment sector.  
2Results not shown because of small cell size. Small cell size determined by calculating the expected number of cases based on the percentage of people with the outcome and the total number of people with the 
condition. If the expected value was less than five, then the OR is dashed out.
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Appendix table 3. Predictors of treatment dropout within each country income group respondents with at least one disorder in the 12 months before interview who received mental health 
treatment in the past 12 months in the World Mental Health Surveys, by country income group 
   
 1-2 visits 3+ visits 
 
Any of the 
three services 
Psychiatrist 
(whether or not 
received other 
service) 
Not psychiatrist 
but other mental 
health (whether 
or not received 
general medical) 
General medical 
(only) 
Any of the 
three services 
Psychiatrist 
(whether or not 
received other 
service) 
Not psychiatrist but 
other mental health  
(whether or not 
received general 
medical) 
General medical 
(only) 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
I. High income countries *,1                 
Gender (male vs. female) 1.0 (0.8-1.2) 0.8  (0.4-1.6) 0.7  (0.4-1.2) 1.2  (0.9-1.5) 1.2  (0.8-1.8) 1.6  (1.0-2.5) 1.5  (0.9-2.6) 0.6 (0.3-1.3) 
Age  1.0  (1.0- 1.0) 1.0  (1.0-1.0) 1.0  (1.0-1.0) 1.0*  (1.0-1.0) 1.0*  (1.0-1.0) 1.0*  (0.9-1.0) 1.0  (1.0-1.0) 1.0 (1.0-1.0) 
Education 0.9  (0.8-1.0) 0.9  (0.7-1.1) 1.0  (0.8-1.3) 0.9  (0.8-1.1) 0.9  (0.7-1.1) 0.8  (0.6-1.1) 0.7  (0.5-1.0) 1.3 (0.9-1.8) 
Employed (yes vs. all others) 1.1  (0.9-1.4) 1.0  (0.6-1.6) 0.8  (0.4-1.4) 1.2  (0.9-1.5) 1.0  (0.6-1.5) 2.1*  (1.2-3.8) 0.6  (0.3-1.2) 1.2 (0.6-2.4) 
Family income 1.0  (0.9-1.0) 1.0  (0.8-1.3) 1.1  (0.8-1.5) 1.0  (0.9-1.1) 1.0  (0.8-1.2) 1.0  (0.8-1.2) 0.9  (0.7-1.2) 1.4* (1.0-1.9) 
Marital Status (ref.: married or cohabiting)                    
Previously married 1.2  (1.0-1.6) 0.9  (0.6-1.6) 1.0  (0.6-1.7) 1.5*  (1.2-2.0) 0.5*  (0.3-0.8) 0.7  (0.3-1.5) 0.3*  (0.2-0.5) 0.9 (0.4-1.9) 
Never married 1.2  (0.9-1.5) 1.9*  (1.0-3.6) 0.8  (0.5-1.4) 1.1  (0.8-1.5) 0.6*  (0.4-1.0) 0.9  (0.4-1.8) 0.4*  (0.2-0.7) 0.6 (0.3-1.3) 
 22 (p-value) 3.3  (0.189) 5.8 (0.056) 0.5 (0.782) 8.6 (0.014) 10.0 (0.007) 0.8 (0.672) 24.7 (<.0001) 1.5 (0.471) 
Global 2 (p-value) 8.0  (0.333) 11.4 (0.123) 4.8 (0.683) 21.7 (0.003) 25.8  (0.001) 38.3 (<.0001) 65.7 (<.0001) 13.5 (0.060) 
Sample size 3787 1197 828 1762 2048 972 633 443 
II. Low-Middle income countries             
Gender (female vs. male) 0.8  (0.6-1.1) 0.1*  (0.0-0.4) 0.8  (0.5-1.5) 1.0  (0.6-1.6) 1.4  (0.9-2.3) 0.6  (0.3-1.0) 0.9  (0.6-1.3) 3.7*  (1.8-7.3) 
Age  1.0  (1.0-1.0) 1.0  (1.0-1.0) 1.0  (1.0-1.0) 1.0*  (1.0-1.0) 1.0  (1.0-1.0) 1.0  (1.0- 1.0) 0.9*  (0.9-0.9) 1.0  (1.0-1.0) 
Education 0.9  (0.8-1.1) 1.2  (0.8-1.9) 0.8  (0.6-1.1) 1.0  (0.8-1.2) 0.8  (0.6-1.1) 0.8  (0.6- 1.2) 0.8  (0.6-1.1) 0.7  (0.5-1.1) 
Employed (yes vs. all others) 1.0  (0.7-1.4) 0.8  (0.4-1.7) 0.9  (0.6-1.3) 1.0  (0.6-1.5) 1.0  (0.6-1.7) 1.7  (0.9- 3.3) 1.1  (0.7-1.7) 1.1  (0.8-1.4) 
Family income 1.1  (0.9-1.2) 0.8  (0.6-1.0) 1.0  (0.8-1.2) 1.1  (1.0-1.4) 0.9  (0.8-1.1) 1.2  (1.0- 1.6) 1.3  (1.0-1.7) 0.8*  (0.6-1.0) 
Marital status (ref.: married or cohabiting)     
 
           
Previously married 1.4  (1.0-2.0) 0.8  (0.4-1.6) 1.8  (1.0-3.4) 1.5  (1.0-2.3) 1.2  (0.6-2.4) 0.8 (0.4-1.6) 4.9*  (2.1-11.2)  1.7  (0.8-3.9) 
Never married 1.2 (0.8-1.8) 2.6*  (1.2-5.5) 1.2  (0.7-2.3) 1.2  (0.6-2.2) 0.8 (0.4-1.4) 0.5 (0.2-1.3) 0.6*  (0.4-1.0) 1.0  (0.4-2.8) 
22 (p-value) 3.7 (0.158) 8.1 (0.017) 3.7 (0.158) 3.4 (0.188) 1.1 (0.580) 3.1 (0.215) 20.0 (<.0001) 2.2 (0.388) 
Global 2 (p-value) 11.0 (0.140) 22.2 (0.002) 10.1 (0.181) 16.9 (0.018) 6.4 (0.498) 11.8 (0.107) 51.4 (<.0001) 26.9 (0.000) 
Sample size 1203 395 235 573 546 269 103 174 
         
*Significant at the .05 level, two-sided test compared to patients with the omitted category described in parentheses 
1Each model included dummy variable controls for survey, number of visits, number-severity of disorders, and type of insurance. The model for any dropout additionally controlled for treatment sector. 
 
